$1.47
0.68% today
Nasdaq, Dec 30, 10:00 pm CET
ISIN
US68375N1037
Symbol
OPK
Sector
Industry

OPKO Health, Inc. Target price 2024 - Analyst rating & recommendation

OPKO Health, Inc. Classifications & Recommendation:

Buy
100%

OPKO Health, Inc. Price Target

Target Price $3.96
Price $1.48
Potential
Number of Estimates 6
6 Analysts have issued a price target OPKO Health, Inc. 2025 . The average OPKO Health, Inc. target price is $3.96. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 6 analysts: 6 Analysts recommend OPKO Health, Inc. to buy, 0 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the OPKO Health, Inc. stock has an average upside potential 2025 of . Most analysts recommend the OPKO Health, Inc. stock at Purchase.

Sales and Margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Million $ 863.50 684.92
14.01% 20.68%
EBITDA Margin -6.11% -16.86%
55.37% 175.94%
Net Margin -19.76% -16.94%
36.80% 14.27%

6 Analysts have issued a sales forecast OPKO Health, Inc. 2024 . The average OPKO Health, Inc. sales estimate is

$685m
Unlock
. This is
3.72% lower
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$686m 3.56%
Unlock
, the lowest is
$682m 4.13%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $864m 14.01%
2024
$685m 20.68%
Unlock
2025
$685m 0.00%
Unlock
2026
$734m 7.19%
Unlock
2027
$775m 5.50%
Unlock
2028
$855m 10.38%
Unlock

2 Analysts have issued an OPKO Health, Inc. EBITDA forecast 2024. The average OPKO Health, Inc. EBITDA estimate is

$-116m
Unlock
. This is
44.84% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$-60.9m 70.92%
Unlock
, the lowest is
$-170m 18.77%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 $-52.8m 61.62%
2024
$-116m 118.92%
Unlock
2025
$11.0m 109.52%
Unlock
2026
$57.1m 418.64%
Unlock
2027
$73.7m 29.18%
Unlock
2028
$132m 78.43%
Unlock

EBITDA Margin

2023 -6.11% 55.37%
2024
-16.86% 175.94%
Unlock
2025
1.61% 109.55%
Unlock
2026
7.77% 382.61%
Unlock
2027
9.52% 22.52%
Unlock
2028
15.38% 61.55%
Unlock

1 Analyst has issued a net profit forecast OPKO Health, Inc. 2024 . The average OPKO Health, Inc. net profit estimate is

$-116m
Unlock
. This is
10.53% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-116m 10.53%
Unlock
, the lowest is
$-116m 10.53%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $-171m 45.65%
2024
$-116m 32.00%
Unlock
2025
$-102m 11.77%
Unlock
2026
$-81.9m 20.00%
Unlock
2027
$-47.8m 41.67%
Unlock
2028
$0.0 100.00%
Unlock

Net Margin

2023 -19.76% 36.80%
2024
-16.94% 14.27%
Unlock
2025
-14.95% 11.75%
Unlock
2026
-11.16% 25.35%
Unlock
2027
-6.17% 44.71%
Unlock
2028
0.00% 100.00%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Earnings Per Share $ -0.25 -0.17
45.65% 32.00%
P/E negative
EV/Sales 1.63

1 Analysts have issued a OPKO Health, Inc. forecast for earnings per share. The average OPKO Health, Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$-0.17
Unlock
. This is
10.53% higher
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$-0.17 10.53%
Unlock
, the lowest is
$-0.17 10.53%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $-0.25 45.65%
2024
$-0.17 32.00%
Unlock
2025
$-0.15 11.76%
Unlock
2026
$-0.12 20.00%
Unlock
2027
$-0.07 41.67%
Unlock
2028
$0.00 100.00%
Unlock

P/E ratio

Current -7.62 31.61%
2024
-8.71 14.30%
Unlock
2025
-9.87 13.32%
Unlock
2026
-12.33 24.92%
Unlock
2027
-21.14 71.45%
Unlock

Based on analysts' sales estimates for 2024, the OPKO Health, Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 1.57 3.09%
2024
1.63 3.78%
Unlock
2025
1.63 0.00%
Unlock
2026
1.52 6.71%
Unlock
2027
1.44 5.21%
Unlock
2028
1.31 9.40%
Unlock

P/S ratio

Current 1.42 0.48%
2024
1.47 3.87%
Unlock
2025
1.47 0.00%
Unlock
2026
1.38 6.70%
Unlock
2027
1.30 5.21%
Unlock
2028
1.18 9.41%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today